Literature DB >> 34020940

Aminoglycosides Antagonize Bacteriophage Proliferation, Attenuating Phage Suppression of Bacterial Growth, Biofilm Formation, and Antibiotic Resistance.

Pengxiao Zuo1, Pingfeng Yu1, Pedro J J Alvarez1.   

Abstract

The common cooccurrence of antibiotics and phages in both natural and engineered environments underscores the need to understand their interactions and implications for bacterial control and antibiotic resistance propagation. Here, aminoglycoside antibiotics that inhibit protein synthesis (e.g., kanamycin and neomycin) impeded the replication of coliphage T3 and Bacillus phage BSP, reducing their infection efficiency and mitigating their hindrance of bacterial growth, biofilm formation, and tolerance to antibiotics. For example, treatment with phage T3 reduced subsequent biofilm formation by Escherichia coli liquid cultures to 53% ± 5% of that of the no-phage control, but a smaller reduction of biofilm formation (89% ± 10%) was observed for combined exposure to phage T3 and kanamycin. Despite sharing a similar mode of action with aminoglycosides (i.e., inhibiting protein synthesis) and antagonizing phage replication, albeit to a lesser degree, tetracyclines did not inhibit bacterial control by phages. Phage T3 combined with tetracycline showed higher suppression of biofilm formation than when combined with aminoglycosides (25% ± 6% of the no-phage control). The addition of phage T3 to E. coli suspensions with tetracycline also suppressed the development of tolerance to tetracycline. However, this suppression of antibiotic tolerance development disappeared when tetracycline was replaced with 3 mg/liter kanamycin, corroborating the greater antagonism with aminoglycosides. Overall, this study highlights this overlooked antagonistic effect on phage proliferation, which may attenuate phage suppression of bacterial growth, biofilm formation, antibiotic tolerance, and maintenance of antibiotic resistance genes. IMPORTANCE The coexistence of residual antibiotics and phages is common in many environments, which underscores the need to understand their interactive effects on bacteria and the implications for antibiotic resistance propagation. Here, aminoglycosides acting as bacterial protein synthesis inhibitors impeded the replication of various phages. This alleviated the suppressive effects of phages against bacterial growth and biofilm formation and diminished bacterial fitness costs that suppress the emergence of tolerance to antibiotics. We show that changes in bacteria caused by environmentally relevant concentrations of sublethal antibiotics can affect phage-host dynamics that are commonly overlooked in vitro but can result in unexpected environmental consequences.

Entities:  

Keywords:  antagonism; antibiotic resistance; biofilms; phage therapy; phage-antibiotic combinations

Mesh:

Substances:

Year:  2021        PMID: 34020940      PMCID: PMC8276799          DOI: 10.1128/AEM.00468-21

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  45 in total

Review 1.  Microbiological effects of sublethal levels of antibiotics.

Authors:  Dan I Andersson; Diarmaid Hughes
Journal:  Nat Rev Microbiol       Date:  2014-05-27       Impact factor: 60.633

Review 2.  Aminoglycosides: An Overview.

Authors:  Kevin M Krause; Alisa W Serio; Timothy R Kane; Lynn E Connolly
Journal:  Cold Spring Harb Perspect Med       Date:  2016-06-01       Impact factor: 6.915

3.  Misreading, a fundamental aspect of the mechanism of action of several aminoglycosides.

Authors:  D Lando; M A Cousin; M Privat de Garilhe
Journal:  Biochemistry       Date:  1973-10-23       Impact factor: 3.162

4.  Synthesis of dummy-template molecularly imprinted polymer adsorbents for solid phase extraction of aminoglycosides antibiotics from environmental water samples.

Authors:  Zheng Zhang; Xiaolin Cao; Ziping Zhang; Jungang Yin; Dingnan Wang; Yanan Xu; Wei Zheng; Xinyi Li; Qingsong Zhang; Liwen Liu
Journal:  Talanta       Date:  2019-09-20       Impact factor: 6.057

Review 5.  The factors affecting effectiveness of treatment in phages therapy.

Authors:  Mai Huong Ly-Chatain
Journal:  Front Microbiol       Date:  2014-02-18       Impact factor: 5.640

Review 6.  Phage therapy: An alternative to antibiotics in the age of multi-drug resistance.

Authors:  Derek M Lin; Britt Koskella; Henry C Lin
Journal:  World J Gastrointest Pharmacol Ther       Date:  2017-08-06

7.  Pleiotropy complicates a trade-off between phage resistance and antibiotic resistance.

Authors:  Alita R Burmeister; Abigail Fortier; Carli Roush; Adam J Lessing; Rose G Bender; Roxanna Barahman; Raeven Grant; Benjamin K Chan; Paul E Turner
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-18       Impact factor: 11.205

8.  Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa.

Authors:  Benjamin K Chan; Mark Sistrom; John E Wertz; Kaitlyn E Kortright; Deepak Narayan; Paul E Turner
Journal:  Sci Rep       Date:  2016-05-26       Impact factor: 4.379

9.  Antibiotics: Combatting Tolerance To Stop Resistance.

Authors:  Etthel M Windels; Joran E Michiels; Bram Van den Bergh; Maarten Fauvart; Jan Michiels
Journal:  mBio       Date:  2019-09-10       Impact factor: 7.867

Review 10.  Fitness Trade-Offs Resulting from Bacteriophage Resistance Potentiate Synergistic Antibacterial Strategies.

Authors:  Mihnea R Mangalea; Breck A Duerkop
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

View more
  7 in total

Review 1.  Phage-Antibiotic Therapy as a Promising Strategy to Combat Multidrug-Resistant Infections and to Enhance Antimicrobial Efficiency.

Authors:  Chengxi Liu; Qixuan Hong; Rachel Yoon Kyung Chang; Philip Chi Lip Kwok; Hak-Kim Chan
Journal:  Antibiotics (Basel)       Date:  2022-04-25

2.  Bacteriophage Therapy for the Prevention and Treatment of Fracture-Related Infection Caused by Staphylococcus aureus: a Preclinical Study.

Authors:  Jolien Onsea; Virginia Post; Tim Buchholz; Hella Schwegler; Stephan Zeiter; Jeroen Wagemans; Jean-Paul Pirnay; Maya Merabishvili; Matteo D'Este; Stijn G Rotman; Andrej Trampuz; Michael H J Verhofstad; William T Obremskey; Rob Lavigne; R Geoff Richards; T Fintan Moriarty; Willem-Jan Metsemakers
Journal:  Microbiol Spectr       Date:  2021-12-15

Review 3.  Benefits of Combined Phage-Antibiotic Therapy for the Control of Antibiotic-Resistant Bacteria: A Literature Review.

Authors:  Kevin Diallo; Alain Dublanchet
Journal:  Antibiotics (Basel)       Date:  2022-06-22

4.  Aminoglycoside Antibiotics Inhibit Phage Infection by Blocking an Early Step of the Infection Cycle.

Authors:  Larissa Kever; Aël Hardy; Tom Luthe; Max Hünnefeld; Cornelia Gätgens; Lars Milke; Johanna Wiechert; Johannes Wittmann; Cristina Moraru; Jan Marienhagen; Julia Frunzke
Journal:  mBio       Date:  2022-05-04       Impact factor: 7.786

5.  Evaluation of an Antibiotic Cocktail for Fecal Microbiota Transplantation in Mouse.

Authors:  Jijun Tan; Jiatai Gong; Fengcheng Liu; Baizhen Li; Zhanfeng Li; Jiaming You; Jianhua He; Shusong Wu
Journal:  Front Nutr       Date:  2022-06-03

6.  Phage-Related Ribosomal Proteases (Prps): Discovery, Bioinformatics, and Structural Analysis.

Authors:  Julia A Hotinger; Allison Hannah Gallagher; Aaron E May
Journal:  Antibiotics (Basel)       Date:  2022-08-16

7.  Preclinical Assessment of Bacteriophage Therapy against Experimental Acinetobacter baumannii Lung Infection.

Authors:  Sandra-Maria Wienhold; Markus C Brack; Geraldine Nouailles; Gopinath Krishnamoorthy; Imke H E Korf; Claudius Seitz; Sarah Wienecke; Kristina Dietert; Corinne Gurtner; Olivia Kershaw; Achim D Gruber; Anton Ross; Holger Ziehr; Manfred Rohde; Jens Neudecker; Jasmin Lienau; Norbert Suttorp; Stefan Hippenstiel; Andreas C Hocke; Christine Rohde; Martin Witzenrath
Journal:  Viruses       Date:  2021-12-24       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.